Giardiasis classification

Revision as of 17:49, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Giardiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Giardiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Giardiasis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Giardiasis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Giardiasis classification

CDC on Giardiasis classification

Giardiasis classification in the news

Blogs on Giardiasis classification

Directions to Hospitals Treating Giardiasis

Risk calculators and risk factors for Giardiasis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.

Overview

Giardiasis may be classified based on the duration of clinical manifestations into either acute (2-4 weeks) or chronic (more than 4 weeks).

Classification

Giardiasis may be classified based on the duration of clinical manifestations into:

  • Acute (less than 2-4 weeks of symptoms)
  • Chronic (more than 4 weeks of symptoms)

References

Template:Protozoal diseases